Efficacy and safety of anticholinergic agents applied for day-time or night-time

Not Applicable

• Conditions: Overactive bladder

• Registration Number: JPRN-UMIN000006420
• Lead Sponsor: Jikei University School of Medicine

Brief Summary

There were no significant differences between the nighttime and daytime treatment of tolterodine in terms of the adverse events such as thirsty in OAB patients. However, the limitation of this study is a few registrated number of patient (n=10), so that further stufy will be needed to clalify this point.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-11-01
• Study Completion: 2012-10-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1.Urinary retention has occured through the latest 1 year. 2.Post voied residual urine volume is more than 100ml. 3.The treatment has been already done. 4.Patients have sleep disturbance. 5.Patients have irregular life styles. 6.Patients have inhibited diseases for the use of anticholinergic agents.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The presence of dry mouth induced by Detrusitol, an anticholinergic agent, applied for day-time or night-time will be investigated.